
Herpes zoster vaccine not cost-effective in adults aged 50 years
(HealthDay)—For adults aged 50 years, herpes zoster (HZ) vaccine does not appear to be cost-effective, according to a study published online Sept. 8 in the Annals of Internal Medicine.
Sep 8, 2015
0
15